A prospective, randomised, double-blind, multicentre, phase III clinical study on transarterial chemoembolisation (TACE) combined with sorafenib versus TACE plus placebo in patients with hepatocellular cancer (HCC) before liver transplantation (LTx) -Heidelberg Liver Cancer Study (HeiLivCa Study)

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2008
This article has no abstract
Epistemonikos ID: 7e08c266052c7ba863fee1e3ba5ec2d7e990e6f0
First added on: Jan 17, 2025